AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 287: E977-E982, 2004. First published June 15, 2004; doi:10.1152/ajpendo.00139.2004
0193-1849/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/5/E977    most recent
00139.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erol, E.
Right arrow Articles by Binas, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erol, E.
Right arrow Articles by Binas, B.

Nonacute effects of H-FABP deficiency on skeletal muscle glucose uptake in vitro

Erdal Erol,1 Gary W. Cline,2 Jason K. Kim,2 Heinrich Taegtmeyer,3 and Bert Binas1

1Department of Pathobiology, College of Veterinary Medicine, Texas A&M University, College Station 77843; 3Division of Cardiology, University of Texas Houston Medical School, Houston, Texas 77030; and 2Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06536

Submitted 23 March 2004 ; accepted in final form 10 June 2004

Heart-type fatty acid-binding protein (H-FABP) is required for high rates of skeletal muscle long-chain fatty acid (LCFA) oxidation and esterification. Here we assessed whether H-FABP affects soleus muscle glucose uptake when measured in vitro in the absence of LCFA. Wild-type and H-FABP null mice were fed a standard chow or high-fat diet before muscle isolation. With the chow, the mutation increased insulin-dependent deoxyglucose uptake by 141% (P < 0.01) at 0.02 mU/ml of insulin but did not cause a significant effect at 2 mU/ml of insulin; skeletal muscle triglyceride and long-chain acyl-CoA (LCA-CoA) levels remained normal. With the high-fat diet, the mutation increased insulin-dependent deoxyglucose uptake by 190% (P < 0.01) at 2 mU/ml of insulin, thus partially preventing insulin resistance, and it completely prevented the threefold (P < 0.001) diet-induced increase of muscle triglyceride levels; however, muscle LCA-CoA levels showed little or no reduction. With both diets, the mutation reduced the basal (insulin-independent) soleus muscle deoxyglucose uptake by 28% (P < 0.05). These results establish a close relation between FABP-dependent lipid pools and insulin sensitivity and indicate the existence of a nonacute, antagonistic, and H-FABP-dependent fatty acid regulation of basal and insulin-dependent muscle glucose uptake.

heart-type fatty acid-binding protein; insulin; insulin resistance



Address for reprint requests and other correspondence: B. Binas, Dept. of Pathobiology, College of Veterinary Medicine, Texas A&M Univ., College Station, TX 77843-4467 (E-mail: bbinas{at}cvm.tamu.edu)




This article has been cited by other articles:


Home page
DiabetesHome page
J. Shearer, P. T. Fueger, D. P. Bracy, D. H. Wasserman, and J. N. Rottman
Partial Gene Deletion of Heart-Type Fatty Acid-Binding Protein Limits the Severity of Dietary-Induced Insulin Resistance
Diabetes, November 1, 2005; 54(11): 3133 - 3139.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.